Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 28,527 |
|
|||||
| News | - | ||||||
| Day High | 1,047.45 | Low High |
|||||
| Day Low | 1,044.21 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.735 | 0.07% | 1,046.105 | 09:02:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,046.50 | 1,044.21 | 1,047.45 | 1,045.37 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,297 | 28,527 | US$ 1,046.50 | US$ 29,853,617 | - | 684.805 - 1,049.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:02:30 | 1 | US$ 1,045.8657 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 114.74B | 109.76M | - | 13.12B | 3.95B | 36.02 | 29.02 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 998.08 | 1,049.50 | 997.84 | 1,029.17 | 401,016 | 48.03 | 4.81% |
| 1 Month | 987.99 | 1,049.50 | 952.30 | 998.23 | 387,342 | 58.12 | 5.88% |
| 3 Months | 961.99 | 1,049.50 | 875.225 | 952.14 | 428,895 | 84.12 | 8.74% |
| 6 Months | 853.78 | 1,049.50 | 838.455 | 941.07 | 481,129 | 192.33 | 22.53% |
| 1 Year | 778.96 | 1,049.50 | 684.805 | 861.75 | 508,460 | 267.15 | 34.30% |
| 3 Years | 534.66 | 1,049.50 | 523.2909 | 719.34 | 632,668 | 511.45 | 95.66% |
| 5 Years | 311.10 | 1,049.50 | 271.37 | 596.60 | 760,264 | 735.01 | 236.26% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
